NCM
Nantahala Capital Management Portfolio holdings
AUM
$1.41B
1-Year Return
32.9%
This Quarter Return
-1.83%
1 Year Return
+32.9%
3 Year Return
+104.34%
5 Year Return
+145.08%
10 Year Return
+443.66%
AUM
$1.21B
AUM Growth
-$221M
(-15%)
Cap. Flow
-$144M
Cap. Flow
% of AUM
-11.9%
Top 10 Holdings %
Top 10 Hldgs %
42.91%
Holding
147
New
18
Increased
38
Reduced
57
Closed
11
Top Buys
| 1 |
RH
RH
|
+$11.8M |
| 2 |
Hilton Grand Vacations
HGV
|
+$9.57M |
| 3 |
Gogo Inc
GOGO
|
+$8.54M |
| 4 |
THRD
Third Harmonic Bio
THRD
|
+$8.46M |
| 5 |
Avalo Therapeutics
AVTX
|
+$7.21M |
Top Sells
| 1 |
Soleno Therapeutics
SLNO
|
+$155M |
| 2 |
Peloton Interactive
PTON
|
+$18.1M |
| 3 |
BlackSky Technology
BKSY
|
+$14.9M |
| 4 |
Pathward Financial
CASH
|
+$14.1M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$13.7M |
Sector Composition
| 1 | Healthcare | 63.52% |
| 2 | Consumer Discretionary | 15.44% |
| 3 | Communication Services | 7.06% |
| 4 | Financials | 4.59% |
| 5 | Industrials | 3.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
RAPT Therapeutics
RAPT
$268M
| $6.12M | 0.24% |
626,616
+471,177
| +303% | +$4.6M |
|
|
AVR
52
Anteris Technologies Global Corp. Common Stock
AVR
$201M
| $5.95M | 0.24% |
1,663,666
-3,000
| -0.2% | -$10.7K |
|
|
53
iShares Russell 2000 ETF
IWM
$66.9B
| $5.82M | 0.23% |
29,151
-68,486
| -70% | -$13.7M |
|
54
Assertio
ASRT
$78.3M
| $5.69M | 0.23% |
8,439,762
+291,426
| +4% | +$197K |
|
55
Unicycive Therapeutics
UNCY
$68.4M
| $5.4M | 0.21% |
939,199
-100,000
| -10% | -$575K |
|
56
Xtant Medical Holdings
XTNT
$82.2M
| $5.36M | 0.21% |
11,394,000
| – | – |
|
57
Nektar Therapeutics
NKTR
$926M
| $5.3M | 0.21% |
519,270
-1,397
| -0.3% | -$14.2K |
|
58
Cogent Biosciences
COGT
$1.77B
| $5.05M | 0.2% |
843,489
-9,366
| -1% | -$56.1K |
|
59
VistaGen Therapeutics
VTGN
$104M
| $4.95M | 0.2% |
1,978,492
-3,488
| -0.2% | -$8.72K |
|
60
Noodles & Co
NDLS
$30.7M
| $4.91M | 0.2% |
4,505,489
-2,840
| -0.1% | -$3.1K |
|
61
Alta Equipment Group
ALTG
$239M
| $4.89M | 0.19% |
1,042,769
+197,654
| +23% | +$927K |
|
62
Xencor
XNCR
$613M
| $4.86M | 0.19% |
+456,741
| New | +$4.86M |
|
63
Fossil Group
FOSL
$168M
| $4.82M | 0.19% |
4,189,177
+862,500
| +26% | +$992K |
|
64
Inhibikase Therapeutics
IKT
$116M
| $4.8M | 0.19% |
2,190,000
| – | – |
|
65
TELA Bio
TELA
$62.6M
| $4.73M | 0.19% |
3,877,965
+198,239
| +5% | +$242K |
|
|
CRGX
66
DELISTED
CARGO Therapeutics
CRGX
| $4.48M | 0.18% |
+1,100,000
| New | +$4.48M |
|
67
Apyx Medical
APYX
$79.4M
| $4.46M | 0.18% |
3,258,048
+88,248
| +3% | +$121K |
|
68
Rocket Pharmaceuticals
RCKT
$341M
| $4.2M | 0.17% |
+629,749
| New | +$4.2M |
|
69
Tango Therapeutics
TNGX
$727M
| $4.09M | 0.16% |
2,987,983
+183,573
| +7% | +$251K |
|
70
Anebulo Pharmaceuticals
ANEB
$97.4M
| $3.95M | 0.16% |
3,036,325
| – | – |
|
71
Kosmos Energy
KOS
$799M
| $3.91M | 0.16% |
+1,716,593
| New | +$3.91M |
|
72
Eledon Pharmaceuticals
ELDN
$145M
| $3.87M | 0.15% |
1,141,237
-6,709
| -0.6% | -$22.7K |
|
73
Akebia Therapeutics
AKBA
$782M
| $3.84M | 0.15% |
+2,000,000
| New | +$3.84M |
|
74
Neuropace
NPCE
$326M
| $3.84M | 0.15% |
312,094
-249,979
| -44% | -$3.07M |
|
75
Rezolute
RZLT
$669M
| $3.75M | 0.15% |
1,291,395
-1,566,587
| -55% | -$4.54M |
|